AbbVie’s former CEO Richard Gonzalez—who collected a $25.7 million payout for his final full year on the job in 2023—often ranked among the industry’s highest-paid CEOs during his tenure ...

IANS Amaravati, March 9 (IANS) In the wake of Andhra Pradesh Chief Minister and TDP President Chandrababu Naidu advocating incentives for families to have more children, party MP from Vizianagaram ...

Rumor mill: Following the disappointing launches of Nvidia's RTX 5090, 5080, 5070 Ti, and 5070 graphics cards, the Blackwell lineup's mainstream and entry-level products are expected to emerge soon.

VIJAYAWADA: Chief Minister and TDP supremo N Chandrababu Naidu on Sunday night announced the names of Kavali Greeshma, Beeda Ravichandra and BT Naidu as party candidates for three MLC seats under ...

Whales with a lot of money to spend have taken a noticeably bullish stance on AbbVie. Looking at options history for AbbVie ABBV we detected 29 trades. If we consider the specifics of each trade ...

The therapy, dubbed DNL343, is designed to activate the protein complex eIF2B, protecting neurons by preventing further aggregation of the TDP-43 protein ... Rival AbbVie and Denali prospects ...

Earlier this week, AbbVie ABBV announced that it is in-licensing rights to develop phase I candidate, GUB014295, a long-acting amylin analog for the treatment of obesity, from Danish research ...

AbbVie was downgraded to "Hold" due to high debt, fluctuating earnings, and declining Humira sales, but the stock outperformed with a 31% return since July 2024. Despite mixed quarterly results ...

Our reporting shows this will be painful for many biopharma companies who rely on funds from the sale of PRVs. Speaking of money, AbbVie and Eli Lilly struck a pair of mid-size deals in hot spaces.

AbbVie said on Monday that it will pay up to $2.2 billion to develop Danish drugmaker Gubra's experimental obesity drug, marking its late foray into the segment. Under the terms of the deal, the ...